John Overdeck’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $326K | Sell |
900
-7,900
| -90% | -$2.7M | ﹤0.01% | 4468 |
|
|
2026
Q1 | $3.1M | Sell |
8,800
-800
| -8% | -$285K | ﹤0.01% | 2416 |
|
|
2025
Q4 | $3.14M | Buy |
+9,600
| New | +$3.05M | ﹤0.01% | 2108 |
|
|
2022
Q1 | – | Sell |
-31,100
| Closed | -$7M | – | 2637 |
|
|
2021
Q4 | $7M | Sell |
31,100
-75,000
| -71% | -$15.8M | 0.01% | 1005 |
|
|
2021
Q3 | $22.6M | Buy |
106,100
+83,200
| +363% | +$19.1M | 0.05% | 428 |
|
|
2021
Q2 | $5.58M | Buy |
22,900
+8,600
| +60% | +$2.12M | 0.01% | 1130 |
|
|
2021
Q1 | $3.56M | Buy |
14,300
+300
| +2% | +$71.6K | 0.01% | 1280 |
|
|
2020
Q4 | $3.22M | Buy |
14,000
+2,600
| +23% | +$599K | 0.01% | 1187 |
|
|
2020
Q3 | $2.9M | Buy |
11,400
+8,200
| +256% | +$2.03M | 0.01% | 1091 |
|
|
2020
Q2 | $755K | Sell |
3,200
-11,700
| -79% | -$2.67M | ﹤0.01% | 1719 |
|
|
2020
Q1 | $3.02M | Sell |
14,900
-3,000
| -17% | -$655K | 0.02% | 748 |
|
|
2019
Q4 | $4.32M | Sell |
17,900
-1,600
| -8% | -$353K | 0.01% | 1051 |
|
|
2019
Q3 | $3.77M | Sell |
19,500
-24,900
| -56% | -$4.78M | 0.01% | 1022 |
|
|
2019
Q2 | $8.18M | Buy |
44,400
+39,600
| +825% | +$7.09M | 0.03% | 678 |
|
|
2019
Q1 | $912K | Buy |
+4,800
| New | +$917K | ﹤0.01% | 1885 |
|
|
2018
Q4 | – | Sell |
-28,700
| Closed | -$5.95M | – | 2949 |
|
|
2018
Q3 | $5.95M | Sell |
28,700
-150,100
| -84% | -$29.6M | 0.02% | 871 |
|
|
2018
Q2 | $33M | Buy |
178,800
+163,800
| +1,092% | +$29M | 0.1% | 276 |
|
|
2018
Q1 | $2.56M | Buy |
15,000
+7,700
| +105% | +$1.41M | 0.01% | 1354 |
|
|
2017
Q4 | $1.27M | Sell |
7,300
-12,700
| -64% | -$2.25M | ﹤0.01% | 1795 |
|
|
2017
Q3 | $3.73M | Buy |
20,000
+11,000
| +122% | +$1.95M | 0.01% | 950 |
|
|
2017
Q2 | $1.55M | Sell |
9,000
-5,000
| -36% | -$813K | 0.01% | 1593 |
|
|
2017
Q1 | $2.3M | Hold |
14,000
| – | – | 0.01% | 1372 |
|
|
2016
Q4 | $2.05M | Sell |
14,000
-3,000
| -18% | -$452K | 0.01% | 1473 |
|
|
2016
Q3 | $2.84M | Buy |
17,000
+5,000
| +42% | +$846K | 0.01% | 1218 |
|
|
2016
Q2 | $1.83M | Buy |
12,000
+6,000
| +100% | +$933K | 0.01% | 1326 |
|
|
2016
Q1 | $900K | Sell |
6,000
-16,000
| -73% | -$2.38M | ﹤0.01% | 1662 |
|
|
2015
Q4 | $3.57M | Buy |
+22,000
| New | +$3.46M | 0.02% | 799 |
|
|
2015
Q3 | – | Sell |
-14,000
| Closed | -$2.15M | – | 2164 |
|
|
2015
Q2 | $2.15M | Buy |
14,000
+10,000
| +250% | +$1.6M | 0.01% | 1147 |
|
|
2015
Q1 | $639K | Buy |
+4,000
| New | +$630K | ﹤0.01% | 1837 |
|
Other funds holding AMGN
John Overdeck's AMGN Position: Q2 2026 in Review
John Overdeck increased its Amgen (AMGN) stake by 1,475% in Q2 2026, buying an estimated $362M and bringing the position to 1,128,681 shares worth $409M. The position accounts for 0.3% of the portfolio, ranked #62.
John Overdeck first reported a position in AMGN in Q4 2013 and has held it in 47 quarters since. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- John Overdeck held 1,128,681 shares of Amgen worth $409M as of Q2 2026.
- John Overdeck bought 1,057,001 Amgen shares in Q2 2026, an estimated $362M.
- Amgen made up 0.3% of John Overdeck's portfolio in Q2 2026, its #62 holding.
- John Overdeck first reported a position in Amgen in Q4 2013 and has held it in 47 quarters since.
- 3,137 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.